Abstract
The dopamine transporter (DAT) has been shown to be a sensitive indicator of nigrostriatal dopamine function. Although visual inspection is often sufficient to assess DAT imaging, quantification could improve the diagnostic accuracy of single-photon emission tomography (SPET) studies of the dopaminergic system. The aim of this study was to assess the accuracy of quantification of the striatal/background uptake ratio when correction for attenuation, scatter and spatially variant fan-beam collimator response is performed in technetium-99m and iodine-123 SPET imaging. A numerical striatal phantom was implemented, and simulated projections of low-energy photons were obtained by using the SimSET Monte Carlo code. High-energy contamination in 123I studies was modelled from experimental measurements with 99mTc and 123I. The ordered subsets expectation maximisation (OSEM) algorithm was employed in reconstruction. Mean improvements of 8% and 16% were obtained in the calculated striatal/background uptake ratio in the putamen and the caudate, respectively, when the spatially variant point spread function was included in the transition matrix. Ideal scatter correction resulted in improvements in the putamen and caudate of 9% for 99mTc agents and 19% for 123I agents. Improvements averaged 31% in the putamen and 43% in the caudate when correction for attenuation, scatter and spatially variant collimator response was included in the reconstruction.
Similar content being viewed by others
References
Tatsch K. Imaging of the dopaminergic system in parkinsonism with SPET. Nucl Med Commun 2001; 22:819–827.
Pilowsky LS. Probing targets for antipsychotic drug with PET and SPET receptor imaging. Nucl Med Commun 2001; 22:829–833.
Acton PD, Choi S-R, Plössl K, Kung HF. Quantification of dopamine transporters in the mouse brain using ultra-high resolution single-photon emission tomography. Eur J Nucl Med Mol Imaging 2002; 29:691–698.
Tatsch K. Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease?. Eur J Nucl Med Mol Imaging 2002; 29:711–714.
Frey KA. Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease? Eur J Nucl Med Mol Imaging 2002; 29:715–717.
Booij J, Tissingh G, Winogrodzka a, Van Royen EA. Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism. Eur J Nucl Med 1999; 26:171–182.
Neumeyer JL, Wang S, Milius RA et al. N-omega-fluooalkyl analogs of (IR)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)-tropane (beta-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters. J Med Chem 1994; 37:558–561.
Kung MP, Stevenson DA, Plössl K, Meegalla SK, Beckwith A, Essman WD, Mu M, Lucki I, Kung HF. [99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent. Eur J Nucl Med 1997; 24:372–380.
Johannsen B, Pietzsch HJ. Development of technetium-99m-based CNS receptor ligands: have there been any advances?. Eur J Nucl Med Mol Imaging 2002; 29:263–275.
El Fakhri G, Moore SC, Maksud P, Aurengo A, Kijewski MF. Absolute activity quantitation in simultaneous123I/99mTc brain SPECT. J Nucl Med 2001; 42:300–308.
Habraken JB, Booij J, Slomka P, Sokole EB, von Royen EA. Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm. J Nucl Med 1999; 40:1091–1097.
Radau P, Linke R, Slomka PJ, Tatsch K. Optimization of automated quantification of123I-IBZM uptake in the striatum applied to parkinsonism. J Nucl Med 2000; 41:220–227.
Booij J, Tissingh G, Boer GJ, Speelman JD, Stoof JC, Janssen AGM, Wolters EC, Vanroyen EA [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 1997; 62:133–140.
Mozley PD, Schneider JS, Acton PD, Plossl K, Stern MB, Siderowf A, Leopold NA, Li PY, Alavi A, Kung HF. Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers. J Nucl Med 2000; 41:584–589.
Seibyl JP, Marek K, Sheff K, Baldwin RM, Zoghbi S, Zea-Ponce Y, Charney DS, van Dyck CH, Hoffer PB, Innis RB. Test/retest reproducibility of iodine-123-β-CIT SPECT brain measurement of dopamine transporters in Parkinson's patients. J Nucl Med 1997; 38:1453–1459.
Linke R, Gostomzyk J, Hahn K, Tatsch K. [I-123]IPT-binding to the presynaptic dopamine transporter: variation of intra- and interobserver data evaluation in parkinsonian patients and controls. Eur J Nucl Med 2000; 27:1809–1812.
Stoof JC, Winogrodzka A, van Muiswinkel FL, Wolters EC, Voorn P, Groenewegen HJ, Booij J, Drukarch B. Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy. Eur J Pharmacol 1999; 375:75–86.
Hudson HM, Larkin RS. Accelerated image reconstruction using ordered subsets projection data IEEE Trans Med Imaging 1994; 13:601–609.
Harrison RL, Vannoy SD, Haynor SB, Gillispie SB, Kaplan MS, Lewellen TK. Preliminary experience with the photon history generator module of a public-domain simulation system for emission tomography. IEEE NSS-MIC Conf Record 1993; 2:1154–1158.
Salvat F, Fernandez-Varea JM, Acosta E, Sempau J. PENELOPE A Code for Monte Carlo Simulation of Electron and Photon Transport. Nuclear Energy Agency (OECD/NEA), Issy-les-Moulineaux (France), 2001. Available in pdf format at http://www.nea.fr
Cot A, Sempau J, Pareto D, Bullich S, Pavía J, Calviño F, Ros D. Evaluation of the geometric, scatter and septal penetration components in fan beam collimators using Monte Carlo simulation IEEE Trans Nucl Sci 2002; 49:12–16.
El Fakhri G, Maksud P, Kijewski MF, Habert MO, Todd-Pokropek A, Aurengo A, Moore SC. Scatter and cross-talk corrections in simultaneous Tc-99m/I-123 brain SPECT using constrained factor analysis and artificial neural networks. IEEE Trans Nucl Sci 2000; 47:1573–1580.
Buvat I, Rodríguez-Villafuerte M, Todd-Pokropek A, Benali H, Di Paola R. Comparative assessment of nine scatter correction methods based on spectral analysis using Monte Carlo simulations. J Nucl Med 1995; 36:1476–1488.
Pareto D, Pavía J, Falcon C, Juvells I, Ros D. Characterisation of fan-beam collimators. Eur J Nucl Med 2001; 28:144–149.
Pareto D, Cot A, Falcon C, Juvells I, Pavía J, Ros D. Geometrical response modeling in fan beam collimators. A Numerical Simulation. IEEE Trans Nucl Sci 2002; 49:17–24.
Acknowledgements
This work was supported in part by the MCYT (SAF99-0137, SAF2002-04270-C02-01/02) and FIS (PI020485, G03/185, C03/06). D. Pareto was awarded a PhD fellowship by the University of Barcelona.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pareto, D., Cot, A., Pavía, J. et al. Iterative reconstruction with correction of the spatially variant fan-beam collimator response in neurotransmission SPET imaging. Eur J Nucl Med Mol Imaging 30, 1322–1329 (2003). https://doi.org/10.1007/s00259-003-1229-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-003-1229-7